ATE91182T1 - Praenatales screening fuer downs-syndrom. - Google Patents

Praenatales screening fuer downs-syndrom.

Info

Publication number: ATE91182T1
Authority: AT; Austria
Prior art keywords: alpha; syndrome; preatal; screening; dheas
Prior art date: 1987-07-09

Application number

AT88905972T

Other languages

English (en)

Inventor

Nicholas John Wald

Howard Stephen Cuckle

Jacob Abraham Canick

James Edward Haddow

Original Assignee

3I Res Expl Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-07-09

Filing date

1988-07-11

Publication date

1993-07-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26292455&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE91182(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1987-07-09 Priority claimed from GB878716158A external-priority patent/GB8716158D0/en

1987-10-23 Priority claimed from GB878724913A external-priority patent/GB8724913D0/en

1988-07-11 Application filed by 3I Res Expl Ltd filed Critical 3I Res Expl Ltd

1993-07-15 Application granted granted Critical

1993-07-15 Publication of ATE91182T1 publication Critical patent/ATE91182T1/de

Links

201000010374 Down Syndrome Diseases 0.000 title abstract 3
206010044688 Trisomy 21 Diseases 0.000 title abstract 3
238000012216 screening Methods 0.000 title abstract 2
229950009829 prasterone sulfate Drugs 0.000 abstract 3
RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 abstract 2
CZWCKYRVOZZJNM-USOAJAOKSA-N dehydroepiandrosterone sulfate Chemical compound C1[C@@H](OS(O)(=O)=O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC=C21 CZWCKYRVOZZJNM-USOAJAOKSA-N 0.000 abstract 2
PROQIPRRNZUXQM-UHFFFAOYSA-N (16alpha,17betaOH)-Estra-1,3,5(10)-triene-3,16,17-triol Natural products OC1=CC=C2C3CCC(C)(C(C(O)C4)O)C4C3CCC2=C1 PROQIPRRNZUXQM-UHFFFAOYSA-N 0.000 abstract 1
QQIVKFZWLZJXJT-UHFFFAOYSA-N (3alpha,16alpha)-3,16-Dihydroxyandrost-5-en-17-one Natural products C1C(O)CCC2(C)C3CCC(C)(C(C(O)C4)=O)C4C3CC=C21 QQIVKFZWLZJXJT-UHFFFAOYSA-N 0.000 abstract 1
QQIVKFZWLZJXJT-DNKQKWOHSA-N 16alpha-hydroxydehydroepiandrosterone Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H]3CC[C@](C)(C([C@H](O)C4)=O)[C@@H]4[C@@H]3CC=C21 QQIVKFZWLZJXJT-DNKQKWOHSA-N 0.000 abstract 1
102000013529 alpha-Fetoproteins Human genes 0.000 abstract 1
108010026331 alpha-Fetoproteins Proteins 0.000 abstract 1
238000003556 assay Methods 0.000 abstract 1
239000008280 blood Substances 0.000 abstract 1
210000004369 blood Anatomy 0.000 abstract 1
229960004407 chorionic gonadotrophin Drugs 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
PROQIPRRNZUXQM-ZXXIGWHRSA-N estriol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H]([C@H](O)C4)O)[C@@H]4[C@@H]3CCC2=C1 PROQIPRRNZUXQM-ZXXIGWHRSA-N 0.000 abstract 1
230000008774 maternal effect Effects 0.000 abstract 1
239000002207 metabolite Substances 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
230000035935 pregnancy Effects 0.000 abstract 1
229960003387 progesterone Drugs 0.000 abstract 1
239000000186 progesterone Substances 0.000 abstract 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/743—Steroid hormones
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/38—Pediatrics
- G01N2800/385—Congenital anomalies
- G01N2800/387—Down syndrome; Trisomy 18; Trisomy 13

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Biomedical Technology (AREA)
Chemical & Material Sciences (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Cell Biology (AREA)
Biotechnology (AREA)
Food Science & Technology (AREA)
Endocrinology (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Biochemistry (AREA)
Microbiology (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Reproductive Health (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Investigating Or Analysing Biological Materials (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Holo Graphy (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

AT88905972T 1987-07-09 1988-07-11 Praenatales screening fuer downs-syndrom. ATE91182T1 (de)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GB878716158A GB8716158D0 (en)	1987-07-09	1987-07-09	Antenatal screening for down's syndrome
GB878724913A GB8724913D0 (en)	1987-10-23	1987-10-23	Antenatal screening for down's syndrome
PCT/GB1988/000557 WO1989000696A1 (en)	1987-07-09	1988-07-11	Antenatal screening for down's syndrome
EP88905972A EP0362294B1 (de)	1987-07-09	1988-07-11	Pränatales screening für downs-syndrom

Publications (1)

Publication Number	Publication Date
ATE91182T1 true ATE91182T1 (de)	1993-07-15

Family

ID=26292455

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT88905972T ATE91182T1 (de)	1987-07-09	1988-07-11	Praenatales screening fuer downs-syndrom.

Country Status (6)

Country	Link
EP (1)	EP0362294B1 (de)
JP (1)	JP2525474B2 (de)
AT (1)	ATE91182T1 (de)
DE (1)	DE3882140T2 (de)
DK (1)	DK172477B1 (de)
WO (1)	WO1989000696A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5258907A (en) *	1989-01-17	1993-11-02	Macri James N	Method and apparatus for detecting down syndrome by non-invasive maternal blood screening
US5324667A (en) *	1989-01-17	1994-06-28	Macri James N	Method for detecting down sydrown by non-invasive maternal blood screening
US5252489A (en) *	1989-01-17	1993-10-12	Macri James N	Down syndrome screening method utilizing dried blood samples
JP2644373B2 (ja) *	1989-01-17	1997-08-25	ジェイムズエヌマクリ	ダウン症候群スクリーニング法
GB9224965D0 (en) *	1992-11-28	1993-01-20	Kodak Ltd	Antenatal screening for chromosomal abnormalities
GB9306354D0 (en) *	1993-03-26	1993-05-19	Kodak Ltd	Antenatal screening for chromosomal abnormalities
US5583612A (en) *	1994-07-14	1996-12-10	Xerox Corporation	Flexible latch with relaxed engagement
GB9315230D0 (en) *	1993-07-22	1993-09-08	Kodak Ltd	Antenatal screening for chromosomal abnormalities
GB9416415D0 (en) *	1994-08-13	1994-10-05	Kodak Ltd	Antenatel screening for pregnacy abnormalities
GB9606261D0 (en) *	1996-03-25	1996-05-29	Johnson & Johnson Clin Diag	Prenatal screening for fetal abnormalities
KR100459271B1 (ko) *	2002-04-26	2004-12-03	엘지.필립스 엘시디 주식회사	구리 단일막 또는 구리 몰리브덴막의 식각용액 및 그식각방법
WO2012049874A1 (ja) *	2010-10-13	2012-04-19	ヒューマン・メタボローム・テクノロジーズ株式会社	脂肪性肝疾患を診断するためのバイオマーカー、その測定方法、コンピュータプログラム、および、記憶媒体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4454232A (en) *	1982-06-07	1984-06-12	Bio-Rad Laboratories, Inc.	Estriol assay
GR850899B (de) *	1984-04-12	1985-11-25	Gen Hospital Corp
US4670401A (en) *	1985-01-25	1987-06-02	Monell Chemical Senses Center	Axillary androstenol and dehydroepiandrosterone as fertile period onset indicators

1988
- 1988-07-11 AT AT88905972T patent/ATE91182T1/de not_active IP Right Cessation
- 1988-07-11 EP EP88905972A patent/EP0362294B1/de not_active Expired - Lifetime
- 1988-07-11 JP JP63505897A patent/JP2525474B2/ja not_active Expired - Lifetime
- 1988-07-11 WO PCT/GB1988/000557 patent/WO1989000696A1/en not_active Ceased
- 1988-07-11 DE DE88905972T patent/DE3882140T2/de not_active Expired - Lifetime
1989
- 1989-03-09 DK DK198901154A patent/DK172477B1/da not_active IP Right Cessation

Also Published As

Publication number	Publication date
DE3882140T2 (de)	1993-12-23
DK115489A (da)	1989-05-09
DK115489D0 (da)	1989-03-09
JP2525474B2 (ja)	1996-08-21
WO1989000696A1 (en)	1989-01-26
DE3882140D1 (en)	1993-08-05
EP0362294B1 (de)	1993-06-30
EP0362294A1 (de)	1990-04-11
DK172477B1 (da)	1998-09-14
JPH03502483A (ja)	1991-06-06

Similar Documents

Publication	Publication Date	Title
Krantz et al.	2000	First-trimester Down syndrome screening using dried blood biochemistry and nuchal translucency
Spencer et al.	1999	A screening program for trisomy 21 at 10–14 weeks using fetal nuchal translucency, maternal serum free β‐human chorionic gonadotropin and pregnancy‐associated plasma protein‐A
Tulppala et al.	1993	Polycystic ovaries and levels of gonadotrophins and androgens in recurrent miscarriage: prospective study in 50 women
ATE91182T1 (de)	1993-07-15	Praenatales screening fuer downs-syndrom.
US7892774B2 (en)	2011-02-22	Diagnostic method for determining the susceptibility to delivery and reagent kit for use therefor
IL139302A0 (en)	2001-11-25	Antenatal screening for down's syndrome
Wenstrom et al.	1997	α-Fetoprotein, free β-human chorionic gonadotropin, and dimeric inhibin A produce the best results in a three-analyte, multiple-marker screening test for fetal Down syndrome
EP0316919A3 (en)	1990-08-16	Vaginal sample test and reagents
Cuckle et al.	1995	Urinary multiple marker screening for Down's syndrome
IE44204L (en)	1977-12-01	Reagent for pregnancy testing
CA2264840A1 (en)	1998-03-12	Prenatal screening for down's syndrome using hyperglycosylated gonadotropin
DK0409956T3 (da)	1996-04-29	Downs syndrom-screeningmetode
Dumps et al.	2002	Accuracy of single measurements of pregnancy-associated plasma protein-A, human chorionic gonadotropin and progesterone in the diagnosis of early pregnancy failure
JP2005017305A (ja)	2005-01-20	染色体異常に関する出生前スクリーニング
Lam et al.	1998	Second‐trimester maternal serum alpha‐fetoprotein and human chorionic gonadotrophin screening for Down's syndrome in Hong Kong
Wenstrom et al.	1997	Elevated second-trimester dimeric inhibin A levels identify Down syndrome pregnancies
Andersen	1991	Concentrations of free oestradiol and progesterone in human preovulatory follicular fluid
DE69525400D1 (de)	2002-03-21	Vorgeburtliche Überprüfung von Schwangerschaftsabnormitäten
Loncar et al.	1995	Advent of maternal serum markers for Down syndrome screening
Johnson et al.	1993	The role of trophoblast dysfunction in the aetiology of miscarriage
Extermann et al.	1998	Second-trimester maternal serum screening for Down's syndrome: free beta-human chorionic gonadotrophin (HCG) and alpha-fetoprotein, with or without unconjugated oestriol, compared with total HCG, alpha-fetoprotein and unconjugated oestriol.
Akbas et al.	2001	Maternal Serum Screening for Downs Syndrome, Open Neural Tube Defects and Trisomy 18
Spencer	1994	Is the measurement of unconjugated oestriol of value in screening for Down’s syndrome
Massé et al.	2000	Transportation of maternal serum specimens for screening for chromosomal aneuploidies: effect of seasonal variations, distance, and freezing on the stability of the biological markers
JP3440138B2 (ja)	2003-08-25	染色体異常について妊娠期間中にスクリーニングするための方法および装置

Legal Events

Date	Code	Title	Description
2008-10-15	EELA	Cancelled due to lapse of time